Current Perspectives on Cancer Survivorship

CancerCare Connect® Education Workshops are a cost-free way to learn about cancer-related issues from the convenience of your home or office. Leading experts in oncology provide the most up-to-date information on the telephone and online.

This workshop is for patients and their families, partners, caregivers, and friends who are interested in learning more about strategies for living with and managing a cancer diagnosis.

Balancing Work & Cancer Workshop

This FREE workshop for patients, survivors, caregivers and healthcare professionals addresses the practical and legal challenges of work, insurance and finances after a cancer diagnosis.

  • Disclosure
  • Working through diagnosis
  • Job search
  • Taking time off
  • Health insurance options

Palliative & Supportive Care in Oncology Symposium

A team approach to palliative care can, and should, include everyone in an oncology setting: physicians, palliative care specialists, nurses, hospice professionals, social workers, and others. The Palliative and Supportive Care in Oncology Symposium will provide information that is vital to the entire cancer care continuum, from research regarding biologic mechanisms of symptoms to caring for patients’ psychosocial and spiritual needs during cancer treatment and at end of life. Abstracts will be discussed in the General Sessions, as well as in dedicated Oral Abstract Sessions and two all-day poster sessions, showcasing the latest scientific research in palliative and supportive care and its impact on patients with cancer.

5th Annual Metastatic Breast Cancer Conference- Baltimore

The mission of the 5th Annual Metastatic Breast Cancer Conference is to bring together a diverse audience to create a collaborative research environment with a long term goal of developing curative approaches for metastatic breast cancer patients.The Metastatic Breast Cancer Conference was established in 2014 as an annual medical conference for metastatic breast cancer by Theresa’s Research Foundation with leadership from Dr. Matthew Ellis and Dr. Danny Welch. The specific focus on metastatic disease is based on a major unmet clinical need (incurability); thereby distinguishing this conference from other breast cancer-centered conferences. The first conference was hosted at the University of Kansas Cancer Center. In 2015, 2016 and 2017 the MBCC was hosted at Baylor College of Medicine.

The objectives of the conference are to:

  1. Improve palliative care and end of life counseling for patients with metastatic breast cancer.
  2. Implement evidence-based recommendations for treatment of metastatic breast cancer and its subtypes.
  3. Describe how clinical trials can help improve treatment of metastatic breast cancer.
  4. Discuss how drug resistance pathways can be applied to the treatment of metastatic breast cancer in order to improve outcomes and quality of life.
  5. Discuss how biomarkers and genomic analysis can be applied to the treatment of metastatic breast cancer in order to improve outcomes and quality of life.

Bay Area Metastatic Breast Cancer Symposium

Are you a metastatic breast cancer patient or close to someone who is? Join us for an informative and inspiring program. Learn about new and future treatments, how to navigate in the clinical trial jungle, how to live with metastatic disease, how you can help to make a difference, and meet and connect with others in the Mets community.

Distinguished Speakers:

  • Adiba Barney – Patient Advocate, Bay Area CA
  • Elly Cohen, PhD – Clinical Trials,
  • Eileen Consorti, MD – Breast Program Director, Sutter Health, ABSMC
  • Jennifer Klemp, PhD, MPH – Survivorship, Univ of Kansas Cancer Center
  • Sherri Mills, MS, PhD – Genomic Testing, Foundation Medicine
  • Melinda Telli, MD – Treatment, Stanford Univ Med Center


Quality of life in clinical trials & in clinical practice

The European School Oncology (ESO) will host a free e-learning session with experts in the field entitled, “Quality of life in clinical trials and in clinical practice”

Core Outcome Assessments in Cancer Clinical Trials

The Core Outcome Assessments in Cancer Clinical Trials workshop is a full-day workshop that aims to bring together international regulators, payers, members of industry and academia, and patients to advance the science of clinical outcome assessments, which is measuring how patients feel and function. This year’s event will focus on patient-related outcomes (PROs) as they relate to clinical trials, and the FDA Oncology Center of Excellence will use the venue to clarify its position on measuring PROs.

This annual event examines topics beyond the standard assessment endpoints of survival and tumor measurements, including improving methods to quantify how patients experience symptoms and the impact on physical functional outcomes and health-related quality of life.

Current Perspectives on Cancer Survivorship

Topics Covered

  • Overview of Cancer Survivorship
  • Managing Post-Treatment Late Effects
  • The Importance of Treatment Summaries
  • Follow-Up with Your Oncologist & Primary Care Doctor
  • The Benefits of Communicating with Your Health Care Team
  • Quality-of-Life Concerns
  • Questions for Our Panel of Experts

Up ↑